Ramiro Martin Cabral - 01 Mar 2026 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role: Executive Vice President - Elanco International
Signature: /s/ Amy C. Seidel, as Attorney-in-Fact for Ramiro Martin Cabral
Issuer symbol: ELAN
Transactions as of: 01 Mar 2026
Net transactions value: -$795,960
Form type: 4
Filing time: 03 Mar 2026, 19:17:41 UTC
Previous filing: 05 Mar 2025
Next filing: 05 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Cabral Ramiro Martin	Executive Vice President - Elanco International	C/O ELANCO ANIMAL HEALTH INCORPORATED, 450 ELANCO CIRCLE, INDIANAPOLIS	/s/ Amy C. Seidel, as Attorney-in-Fact for Ramiro Martin Cabral	03 Mar 2026	0001752437

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELAN	Common Stock	Award	$0	+60,053	+25%	$0.000000	299,682	01 Mar 2026	Direct
transaction	ELAN	Common Stock	Tax liability	$795,960	-30,150	-10%	$26.40	269,532	01 Mar 2026	Direct
transaction	ELAN	Common Stock	Award	$0	+20,834	+7.7%	$0.000000	290,366	01 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELAN	Employee Stock Option (right to buy)	Award	$0	+42,570		$0.000000	42,570	01 Mar 2026	Common Stock	42,570	$26.40	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted stock units vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.
F2	Grant of stock options vesting as follows: one-third vesting on March 1, 2027, one-third vesting on March 1, 2028, and the remaining vesting on March 1, 2029.

Remarks:

Executive Vice President - Elanco International